Published in Drug Law Weekly, May 12th, 2009
In January 2009, Trevena announced that Dr. Ruffolo had joined its Scientific Advisory Board. In addition to that role, he has now agreed to become a member of the company’s Board of Directors. Of his decision to become more involved with Trevena, Dr. Ruffolo commented, “Since I retired from Pharmaceutical R&D, this is the first biotech board position that I have decided to accept. The science underway at this company is tremendously exciting, and the management team is first rate. I look forward to helping build a strong independent drug discovery...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.